CLARITY Act: 40% Passage, 40% Delay, 20% Failure

Passage odds have fallen to a coin flip. The July 4 signing deadline the White House wanted is logistically dead, one Fox Business correspondent tracking the bill said. Senator Cynthia Lummis has named the price of failure: a wait until 2030, because a new Congress would restart the entire process.

The CLARITY Act passed the House 294 to 134, cleared the Senate Banking Committee 15 to 9 on May 14, and landed on the Senate calendar on June 1. Prediction markets priced passage above 70% in May. They now hover between 45% and 59% depending on the platform.

Two fights have fractured at once. An ethics dispute over the President’s crypto holdings. A law-enforcement fight over developer protections in Section 604. Both need resolution before a floor vote.

The Senate has roughly 31 session days before the August recess. No floor date is scheduled. The chamber is competing with surveillance reauthorization, budget work, and must-pass funding bills.

Three paths remain from here. Each carries a different consequence for the assets most exposed to the bill.

Passage before that recess carries roughly 35% to 45% probability. Both poison pills have to be defused in weeks. The ethics fight needs a compromise that gives Democrats enforcement teeth without the White House reading it as targeting the President. The Section 604 fight needs law-enforcement sign-off to release Senators Mark Warner and Catherine Cortez Masto, without stripping the developer protections that keep industry support. The merged bill would then need floor time, 60 votes, House acceptance, and a signature.

If it passes, the SEC-CFTC jurisdiction split is settled. Digital-commodity classification becomes statute instead of agency interpretation. Developer protections and market-structure rules give institutions the durable certainty they have waited for.

XRP carries the most direct exposure. The bill would convert its March 2026 commodity classification from a reversible agency ruling into permanent law. Standard Chartered’s conditional $8 XRP target is built on that scenario plus sustained ETF inflows. Ethereum has real exposure too, with one bank holding a $7,500 conditional 2026 target tied to passage.

One catch: much of this is already partly priced. The market spent the spring expecting passage. A yes vote delivers the catalyst with some of the move already pulled forward. The cleanest gains would accrue to the specific assets whose classification the statute resolves, not to the market broadly.

Delay into 2027 carries roughly 35% to 45% probability. This has quietly become the most likely single outcome. The poison pills prove too tangled to defuse before the recess. Leadership cannot find floor time. The 60 votes do not materialize in the window. The bill slips past August.

Lummis has warned that missing the pre-recess window risks pushing the bill into the political uncertainty of the midterm season. A distracted Senate, a narrowing willingness among Democrats to hand the administration a win, and a calendar that gets worse through the back half of the year all work against a quick revival.

Delay’s market consequence is a slow bleed of the premium that passage optimism built into prices. XRP gives back the conditional premium as the timeline extends. Standard Chartered already cut its near-term XRP target earlier in 2026 citing slow negotiations. Institutional capital that was waiting for statutory certainty keeps waiting.

Delay is not failure. The agency-level classifications from March stay in place. The ETFs keep trading. The framework remains alive for a 2027 vote. The market would spend the second half of 2026 trading without the catalyst it spent the first half anticipating. That absence is itself a drag.

Outright failure to 2030 carries roughly 15% to 25% probability. The least likely of the three, it is no longer a tail risk. The bill does not pass in 2026 and does not get a realistic second chance until a new Congress rebuilds it from scratch. Lummis has named 2030 as the practical horizon for that reset.

Failure does not require a dramatic floor defeat. A quiet death by calendar is more plausible. The two poison pills stay unresolved through the recess. The post-midterm Congress lacks the will or the composition to revive the bill.

Failure’s consequences compound. XRP keeps its March commodity classification, which stays vulnerable to a future administration. The statutory permanence that underwrites the bull case never arrives. The SEC-CFTC jurisdiction split stays unresolved. The developer protections of Section 604 do not become law. ETF pipelines that depend on clear classification stall. The institutional allocation wave that statutory certainty would unlock is deferred for years.

The GENIUS Act’s stablecoin rules, already law, survive regardless. The market is not left with nothing, just without the market-structure framework that matters most.

The deepest cost is the signal. Even with House passage, committee approval, a supportive White House, and broad bipartisan agreement on the underlying goal, Congress could still fail to finish. That tells institutions that US crypto regulation remains a multi-year waiting game.

Three markers separate the paths. First, whether Senate leadership schedules a floor date. That is the clearest passage signal. Until floor time is announced, passage in the window stays aspirational. The longer the calendar stays silent, the more probability shifts from passage toward delay.

Second, whether the two poison pills find compromises. An ethics enforcement mechanism both Democrats and the White House can accept. Law-enforcement sign-off on Section 604 that releases Warner and Cortez Masto.

Third, the prediction markets. They fell from above 70% to the high 40s and 50s as the poison pills hardened. They move first and fastest if either pill softens or a floor date appears. A sustained climb back above 60% signals passage. A slide below 40% signals delay or failure.

For holders of the assets most exposed to CLARITY, XRP above all, the practical read is to size positions for a distribution of outcomes. The bull case is real but conditional on passage. The bear case is real but conditional on failure. The most likely path–delay–sits in between and pulls the conditional premium out without delivering the catastrophe.

A holder who has priced in passage as the base case is over-exposed to the most likely disappointment. A holder who has priced in failure is over-exposed to a deal that could still come together.

For traders, the asymmetry to respect is that passage is partly priced while failure is not. The downside surprise of a confirmed delay or failure may move prices more than the upside surprise of a passage the market half-expects.

For institutions, only passage releases the capital waiting on statutory certainty. An institution modeling its crypto allocation around CLARITY should weight the roughly even odds of passage against the better-than-even combined odds of delay-or-failure. The most likely near-term outcome is continued waiting.

The CLARITY Act spent the first half of 2026 looking like a sure thing and enters its decisive stretch looking like a coin flip with a long tail. Watch the floor calendar, the two poison pills, and the prediction markets, in that order. They will tell you which fork the bill is taking before the headlines confirm it.